Item 8.01 Other Events.
On May 21, 2021, Vir Biotechnology, Inc. (the "Company") and GlaxoSmithKline plc
("GSK") issued a corrected press release announcing that the European Medicines
Agency's Committee for Human Medicinal Products ("CHMP") has issued a positive
opinion following the referral of sotrovimab to the CHMP under Article 5(3) of
Regulation 726/2004. A copy of the corrected press release is attached hereto as
Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit
No. Description
99.1 Corrected Press Release of the Company, dated May 21, 2021.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses